True North Advisors LLC Increases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

True North Advisors LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 54.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 1,760 shares of the healthcare conglomerate’s stock after purchasing an additional 622 shares during the period. True North Advisors LLC’s holdings in UnitedHealth Group were worth $890,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. BlackBarn Capital Partners LP raised its holdings in UnitedHealth Group by 6.7% in the 2nd quarter. BlackBarn Capital Partners LP now owns 32,000 shares of the healthcare conglomerate’s stock valued at $16,296,000 after acquiring an additional 2,000 shares during the last quarter. Insigneo Advisory Services LLC grew its holdings in UnitedHealth Group by 9.0% in the second quarter. Insigneo Advisory Services LLC now owns 10,890 shares of the healthcare conglomerate’s stock valued at $5,546,000 after purchasing an additional 897 shares during the period. Lone Pine Capital LLC purchased a new position in UnitedHealth Group during the second quarter worth approximately $480,903,000. Fred Alger Management LLC raised its position in shares of UnitedHealth Group by 16.7% in the 2nd quarter. Fred Alger Management LLC now owns 103,957 shares of the healthcare conglomerate’s stock worth $52,941,000 after buying an additional 14,880 shares during the period. Finally, Point72 Hong Kong Ltd increased its stake in UnitedHealth Group by 11.2% during the second quarter. Point72 Hong Kong Ltd now owns 22,069 shares of the healthcare conglomerate’s stock worth $11,239,000 after acquiring an additional 2,221 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

UNH opened at $519.08 on Thursday. The business has a fifty day simple moving average of $545.26 and a 200-day simple moving average of $564.10. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The firm has a market cap of $477.70 billion, a PE ratio of 33.49, a P/E/G ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the firm posted $5.83 earnings per share. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.75 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.62%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.19%.

Analysts Set New Price Targets

Several equities analysts recently weighed in on UNH shares. Deutsche Bank Aktiengesellschaft lifted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Oppenheimer upped their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Truist Financial lowered their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Barclays lowered their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Finally, UBS Group reduced their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.